4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-047619
SVP & General Counsel sold 1,529 shares at $19.67 ($30,075)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew SVP & General Counsel | 2020-08-17 | Sale | −1,529 | $19.67 | $30,075 | 51,389 | D: show line 1 in the form |
| Open-market sales · 1,529 sh · avg $19.67 · $30,075 | |||||||
Loading xslF345X03/doc4.xml…